Comments

Novo Nordisk Stock Guidance

NVONYSE

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$50.37

0.190.38%

At close: Dec 15, 4:00 PM EST

$49.76

-0.61-1.20%

After Hours: 7:58 PM EST

Overview News Earnings Options

Guidance

Dividends Analyst Ratings Short Interest Government Trades Stock Report

Novo Nordisk Stock Guidance | NYSE:NVO | Benzinga

Novo Nordisk issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/05/2025	NVO	Novo Nordisk	FY	2025	—	—	—	$49.13B	$50.50B	$48.96B	Get Alert
08/06/2025	NVO	Novo Nordisk	FY	2025	—	—	—	$46.33B	$48.98B	$48.18B	Get Alert
05/07/2025	NVO	Novo Nordisk	FY	2025	—	—	—	$45.02B	$47.47B	$51.98B	Get Alert
02/05/2025	NVO	Novo Nordisk	FY	2025	—	—	—	$49.44B	$53.60B	$47.64B	Get Alert
11/06/2024	NVO	Novo Nordisk	FY	2024	—	—	—	$41.74B	$43.10B	$41.92B	Get Alert
08/07/2024	NVO	Novo Nordisk	FY	2024	—	—	—	$40.55B	$42.56B	$42.86B	Get Alert
05/02/2024	NVO	Novo Nordisk	FY	2024	—	—	—	$40.25B	$42.96B	$41.28B	Get Alert
01/31/2024	NVO	Novo Nordisk	FY	2024	—	—	—	$39.21B	$41.90B	$40.17B	Get Alert
11/02/2023	NVO	Novo Nordisk	FY	2023	—	—	—	$33.07B	$34.62B	$31.83B	Get Alert
08/10/2023	NVO	Novo Nordisk	FY	2023	—	—	—	$31.29B	$32.84B	$32.04B	Get Alert
05/04/2023	NVO	Novo Nordisk	FY	2023	—	—	—	$30.09B	$31.63B	$31.90B	Get Alert
02/01/2023	NVO	Novo Nordisk	FY	2023	—	—	—	$26.76B	$28.18B	$28.77B	Get Alert
11/02/2022	NVO	Novo Nordisk	FY	2022	—	—	—	$23.66B	$24.23B	$22.97B	Get Alert
08/03/2022	NVO	Novo Nordisk	FY	2022	—	—	—	$22.59B	$23.40B	$23.52B	Get Alert
02/02/2022	NVO	Novo Nordisk	FY	2022	—	—	—	$24.04B	$24.90B	$22.48B	Get Alert

FAQ

Q

What is the most recent guidance for Novo Nordisk (NVO)?

A

There have been no specific sales or earnings guidance reported for Novo Nordisk in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Johnson & Johnson

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

Jazz Pharmaceuticals PLC